PA
BIOX icon

Parallel Advisors’s Bioceres Crop Solutions BIOX Stock Holding History

Parallel Advisors’s Portfolio BIOX Stock Details BIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-500
Closed -$3.04K – 3523
2024
Q4 		$3.04K Hold
500
– – ﹤0.01% 2824
2024
Q3 		$3.94K Hold
500
– – ﹤0.01% 2694
2024
Q2 		$5.61K Hold
500
– – ﹤0.01% 2503
2024
Q1 		$6.33K Hold
500
– – ﹤0.01% 2454
2023
Q4 		$6.87K Hold
500
– – ﹤0.01% 2422
2023
Q3 		$5.64K Hold
500
– – ﹤0.01% 2460
2023
Q2 		$6.68K Sell
500
-8
-2% -$94 ﹤0.01% 2326
2023
Q1 		$5.9K Hold
508
– – ﹤0.01% 2353
2022
Q4 		$6.11K Buy
508
+500
+6,250% +$6.49K ﹤0.01% 2240
2022
Q3 		$0 Buy
+8
New +$98 ﹤0.01% 3149

Other funds holding BIOX

FSC
Fourth Sail Capital Camana Bay Grand Cayman, Cayman Islands $608M AUM 48.69% 1-Year Est. Return
SP
Solel Partners Boston, Massachusetts $468M AUM 2.45% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return
BAM
Ballast Asset Management Dallas, Texas $225M AUM 38.45% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Parallel Advisors's BIOX Position: Q1 2025 in Review

Parallel Advisors sold out of Bioceres Crop Solutions (BIOX) in Q1 2025, closing a stake of 500 shares — an estimated $3.04K sold.

Parallel Advisors first reported a position in BIOX in Q3 2022 and held it in 10 quarters. The position peaked at $6.87K in Q4 2023. 38 funds tracked by Wall St. Rank hold BIOX as of Q1 2025.

  • Parallel Advisors reported no remaining Bioceres Crop Solutions position as of Q1 2025 after selling out during the quarter.
  • Parallel Advisors sold 500 Bioceres Crop Solutions shares in Q1 2025, an estimated $3.04K.
  • Parallel Advisors first reported a position in Bioceres Crop Solutions in Q3 2022 and held it in 10 quarters.
  • Parallel Advisors's Bioceres Crop Solutions position peaked at $6.87K in Q4 2023.
  • 38 funds tracked by Wall St. Rank held Bioceres Crop Solutions as of Q1 2025.

Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.